Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
Published on: December 15, 2023
Artificial intelligence in pharmacovigilance: toward real-time, explainable, and global drug-safety systems
Umair Ali1, Syeda Tayyaba Batool2, Raghabendra Kumar Mahato3
1Department of Pharmacy, University of Swabi, Swabi, Pakistan.
None:
The expanding volume and heterogeneity of post-marketing drug-safety data have exposed the limitations of conventional pharmacovigilance systems. Artificial intelligence (AI) offers scalable solutions for detecting adverse drug reactions by integrating electronic health records, spontaneous reporting systems, and patient-generated data. Recent advances in natural language processing and deep learning enable earlier identification of rare and complex safety signals while reducing reporting delays. Nevertheless, issues related to algorithmic transparency, bias, and regulatory oversight remain critical. This letter highlights emerging applications, current challenges, and future directions for responsible AI integration in pharmacovigilance.
Related Concept Videos
Global Regulatory Systems
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Time Course of Drug Effect
Linear time-invariant Systems
The input-output behavior of an LTI system can be fully defined by its response to an impulsive excitation at its input. Once this impulse response is known, the system's reaction to any other input can be...
Global Climate Change
Intrauterine Drug Delivery Systems

